Cell-free fetal DNA in maternal circulation after chorionic villous sampling

Prenatal Diagnosis

Volumn 33, Issue 7, 2013, Pages 695-699

  Di Tommaso, Mariarosaria ^a   Seravalli, Viola ^a   Salvianti, Francesca ^a   Bussani, Cecilia ^a   Pasquini, Lucia ^a   Cordisco, Adalgisa ^a   Pinzani, Pamela ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CELL FREE DNA; CELL FREE FETAL DNA; UNCLASSIFIED DRUG;

ARTICLE; CHORION VILLUS; CIRCULATION; DNA METHYLATION; EMBRYO; EPIGENETICS; FEMALE; FETUS; GENE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MALE; MATERNAL AGE; MATERNAL PLASMA; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; RASSF1A GENE; TRISOMY;

CHORIONIC VILLI SAMPLING; DNA; DNA METHYLATION; FEMALE; FETAL BLOOD; FETOMATERNAL TRANSFUSION; GESTATIONAL AGE; HUMANS; MATERNAL AGE; PARITY; PLACENTA; PREGNANCY; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84880037039     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4155     Document Type: Article

References (25)

1. Zach HP, Zahn V, Herzog B, Stühmer M. On the feto-maternal transfusion of red blood cells during transplacental and para-placental genetic amniocenteses, GeburtshilfeFrauenheilkd 1979;39(5):378-83.
2. Schmidt W, Gabelmann J, Boos R, et al. Foetomaternal transfusions after amniocentesis in early pregnancy - evaluation of 1, 000 cases. Z Geburtshilfe Perinatol 1980; 184(5): 359-65.
3. Bowman JM, Pollock JM. Transplacental fetal hemorrhage after amniocentesis. Obstet Gynecol 1985;66(6):749-54.
4. Jansen MW, Brandenburg H, Wildschut HI, et al. The effect of chorionic villus sampling on the number of fetal cells isolated from maternal blood and on maternal serum alpha-fetoprotein level. Prenat Diagn 1997;17(10):953-9.
5. Li Y, Zimmermann B, Rusterholz C, et al. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 2004;50(6):1002-11.
6. Fan HC, Blumenfeld YJ, Chitkara U et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc. Natl. Acad. Sci. U.S.A. 2008;105:16266-71.
7. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
8. Ashoor G, Syngelaki A, Poon LC, et al. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 2013;41(1):26-32.
9. Bianchi DW. Circulating fetal DNA: its origin and diagnostic potential - a review. Placenta 2004;25(Suppl A):S93-101.
10. Farina A, LeShane ES, Romero R, et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2005;193(2):421-5.
11. Samura O, Miharu N, Hyodo M, et al. Cell-free fetal DNA in maternal circulation after amniocentesis. Clin Chem 2003;49:1193-5.
12. Bussani C, Di Tommaso M, Cioni R, et al. Quantitative variation analysis of fetal DNA in maternal plasma samples collected before and after amniocentesis. J Obstet Gynaecol Res 2011;37(6):571-4.
13. Vora NL, Johnson KL, Peter I, et al. Circulating cell-free DNA levels increase variably following chorionic villus sampling. Prenat Diagn 2010;30(4):325-8.
14. Lambert NC, Lo YM, Erickson TD, et al. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood. 2002;100(8):2845-51.
15. Chan KC, Ding C, Gerovassili A, et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006;52(12):2211-8.
16. Galbiati S, Causarano V, Pinzani P, et al. Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy. Clin Chem Lab Med 2010;48(6):791-4.
17. Blakemore KJ, Baumgarten A, Schoenfeld-Dimaio M, et al. Rise in maternal serum alpha-fetoprotein concentration after chorionic villus sampling and the possibility of isoimmunization. Am J Obstet Gynecol 1986;155(5):988-93.
18. Brambati B, Guercilena S, Bonacchi I, et al. Feto-maternal transfusion after chorionic villus sampling: clinical implications. Hum Reprod 1986;1(1):37-40.
19. Pelikan DM, Kanhai HH, De Groot-Swings GM, et al. Fetomaternal hemorrhage in relation to chorionic villus sampling revisited. Prenat Diagn 2006;26(3):201-5.
20. Jensen TJ, Zwiefelhofer T, Tim RC, et al. High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma. PLoS One 2013;8(3):e57381.
21. Fleischhacker M, Schmidt B Circulating nucleic acids (CNAs) and cancer - a survey. Biochim Biophys Acta 2007;1775:181-232.
22. Lachman E, Hingley SM, Bates G, et al. Detection and measurement of fetomaternal haemorrhage: serum alpha-fetoprotein and the Kleihauer technique. Br Med J 1977;1:1377-1379.
23. Lenke RR, Ashwood ER, Cyr DR, et al. Genetic amniocentesis: significance of intraamniotic bleeding and placental location. Obstet Gynecol 1985;65(6):798-801.
24. Royal College of Obstetricians and Gynaecologists. Clinical green top guidelines: use of anti-D immunoglobulin for Rh prophylaxis (RCOG revised in 2002 and 2011).
25. ACOG Practice Bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology. Int J Gynaecol Obstet 1999 Jul;66(1):63-70.